Eosinophilia associated with clonal T-Cell proliferation

Leukemia and Lymphoma

Volumn 27, Issue 3-4, 1997, Pages 335-342

  Kitano, K ^a   Ichikawa, N ^a   Shimodaira, S ^a   Ito, T ^a   Ishida, F ^a   Kiyosawa, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clonal T cell proliferation; Cytokine; Eosinophilia; HES; IL 5; T cell

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 5;

ARTICLE; EOSINOPHILIA; GENE REARRANGEMENT; HUMAN; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

EID: 0030829932     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709059688     Document Type: Article

References (65)

1. Gabig, T. G. (1991). Hypereosinophilic syndrome. In: Huffman, R., Benz, E. J., Shattil, S. J., Furie, B. and Cohen, H.J. (eds.) Hematology, Basic Principles and Practice. (Churchill Livingstone, New York) pp. 567-571.
2. Campbell, H. D., Tucker, W. Q. J., Hort, Y., Martinson, M. E., Mayo, G. M., Clutterbuck, E. J., Sanderson, C. J. and Young, I. G. (1987). Molecular cloning, nucleotide sequence, and expression of gene encoding human eosinophil factor (interleukin-5). Proc. Natl. Acad. Sci. U.S.A., 84, 6629-6633.
3. Yamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A. and Takatsu, K. (1988). Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med., 167, 43-56.
4. Rennick, D. M., Lee, F. D., Yokota, T., Arai, K., Cantor, H. and Nabel, G. J. (1985). A cloned MCGF cDNA encodes a multilineage hemopoietic growth factor; multiple activities of interleukin-3. J. Immunol., 134, 910-914.
5. Metcalf, D., Begley, C. G., Johnson, G. R., Nicola, N. A., Vadas, M. A., Lopez, A. F., Williamson, D. J., Wong, G. G., Clark, S. C. and Wang, A. (1986). Biologic properties in vitro of a recombinant human granulocyte-macrophage colonystimulating factor. Blood, 67, 37-45.
6. Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomh, H. M. and Rowley, J. D. (1983). Association of an inversion of chromosome 16 with abnormal marrow eosinophilias in acute myelomonocytic leukemia. N. Engl. J. Med., 309, 630-636.
7. Ema, H., Kitano, K., Suda, T., Sato, Y., Muroi, K., Ohta, M., Yoshida, M., Sakamoto, S., Eguchi, M. and Miura, Y. (1990). In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). Blood, 75, 350-356.
8. Kobayashi, H., Kitano, K., Shimodaira, S., Ishida, F., Saito, H., Sonoyama, M., Enokihara, H. and Furuta, S. (1993). Eosinophilia in myelodysplastic syndrome with a (21;21)(q23;q22) translocation. Cancer Genet. Cytogen., 68, 95-98.
9. Catovsky, D., Bernasconi, C., Verdonock, P. J., Postma, A., Hows, J., van der Does-van den Berg, A., Rees, J. K. H., Castelli, G., Morra, E. and Galton, D. A. G. (1980). The association of cosinophilia with lymphoblastic leukemia or lymphoma: a study of seven cases. Br. J. Haematol., 45, 523-534.
10. Fermand, J. P., Mutjavila, M. T., Le Couedic, J. P., Tsapis, A., Berger, R., Modigliani, R., Seligmann, M., Brouet, J. C. and Vainchenker, W. (1993). Role of granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5 in the eosinophilia associated with T-cell lymphoma. Br. J. Haematol., 83, 359-364.
11. Di Biagio, E., Sanchcz-Borges, M., Desenne, J. J., Suarez-Chacon, R., Somoza, R. and Acquatella, G. (1996). Eosinophilia in Hodgkin's disease: a role for interleukin 5. Int. Arch. Allergy Immunol., 110, 244-251.
12. Fauci, A. S., Harley, J. B., Roberts, W. C., Ferrans, V. J., Gralnick, H. R. and Bjorson, B. H. (1982). The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Ann. Intern. Med., 97, 78-92.
13. Weller, P. F. and Bubley, G. J. (1994). The idiopathic hypereosinophilic syndrome. Blood, 83, 2759-2779.
14. O'Shea, J. J., Jaffe, E. S., Lane, H. C., MacDermott, R. P. and Fauci, A. S. (1987). Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis: clinical, pathologic, and immunologic features. Am. J. Med., 82, 539-545.
15. Raghavachar, A., Fleischer, S., Frickhofen, N., Heimpel, H. and Fleischer, B. (1987). T-lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J. Immunol., 139, 3753-3758.
16. Schrezenmeier, H., Thome, S. D., Tewald, F., Fleischer, B. and Raghavachar, A. (1993). Interleukin-5 is the predominant eosinophilopoietin produced by T-lymphocytes in hypereosinophilic syndrome. Exp. Hematol., 21, 358-365.
17. Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T. and Goldman, M. (1994). Clonal proliferation of type 2 helper T-cells in a man with hypereosinophilic syndrome. N. Engl. J. Med., 330, 535-538.
18. + T-cell population able to secrete large amounts of interleukin-5. Blood, 87, 1416-1422.
19. -αβ T-cells with chromosome 16 anomalies. Br. J. Haematol. 92, 315-317.
20. - T-cells associated with abnormal Fas expression and hypereosinophilia. J. Exp. Med., 183, 1071-1082.
21. Limaye, A. P., Abrams, J. S., Silver, J. E., Ottesen, E. A. and Nutman, T. B. (1990). Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in Helminth-infected patients. J. Exp. Med., 172, 399-402.
22. Romagnani, S. (1994). Lymphokine production by human T-cells in disease states. Annu. Rev. Immunol., 12, 227-257.
23. Onishi, T., Kita, H., Weiler, D., Sur, S., Sedgwich, J. B., Calhoun, W. J., Busse, W. W., Abrams, J. S. and Gleich, G. J. (1993). IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis., 147, 901-907.
24. Ying, S., Durham, S. R., Barkans, J., Masuayama, K., Jacobson, M., Rak, S., Lowhagen, O., Moqbel, R., Kay, A. B. and Hamid, Q. A. (1993). T-cells are the principal sourse of interleukin-5 mRNA in allergen-induced rhinitis. Am. J. Respir. Cell Mol. Biol., 9, 356-360.
25. Coffman, R. L., Seymour, B. W. P., Hudak, S., Jackson, J. and Rennick, D. (1989). Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science, 245, 308-310.
26. Dent, L. A., Strath, M., Mellor, A. L. and Sanderson, C. J. (1990). Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med., 172, 1425-1431.
27. Bonifer, R., Neumann, C., Meuer, S., Schulze, G. and Herrmann, F. (1995). Interleukin 5 expressing allergen-specific T-lymphocytes in patients with house dust mite sensitization: analysis at a clonal level. J. Mol. Med., 73, 79-83.
28. Tsutsui, H., Terano, Y., Sakagami, C., Hasegawa, I., Mizoguchi, Y. and Morisawa, S. (1992). Drug-specific T-cells derived from patients with drug-induced allergic hepatitis. J. Immunol., 149, 706-716.
29. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., Seipp, C. A., Simpson, C. and Reichert, C. M. (1985). Observations on the systemic administration of autologeous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485-1492.
30. West, W. H., Tauer, K. W., Yannelli, J. R., Marshall, G. D., Orr, D. W., Thurman, G. B. and Oldman, R. K. (1987). Constant-infusion interleukin-2 in adoptive immunotherapy of advanced cancer. N. Engl. J. Med., 316, 898-905.
31. Ettinghausen, S. E., Moore, J. G., White, D. E., Platanias, L., Young, N. S. and Rosenberg, S. A. (1987). Hematological effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood, 69, 1654-1660.
32. Macdonald, D., Gordon, A. A., Kajitani, H., Enokihara, H. and Barrett, A. J. (1990). Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br. J. Haematol., 76, 168-173.
33. van Haelst Pisani, C., Kovach, J. S., Kita, H., Leiferman, K. M., Gleich, G. J., Silver, J. E., Dennin, R. and Abrams, J. S. (1991). Administration of interleukin-2 (IL-2) results in creased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood, 78, 1538-1544.
34. Enokihara, H., Furusawa, S., Kajitani, H., Hamaguchi, H., Saito, K., Fukuda, T. and Shishido, H. (1988). Interleukin 2 stimulates the T-cells from patients with eosinophilia to produce CFU-Eo growth stimulating factor. Br. J. Haematol., 69, 431-436.
35. Enokihara, H., Furusawa, S., Nakakubo, H., Kajitani, H., Nagashima, S., Saito, K., Shishido, H., Hitoshi, Y., Takatsu, K., Noma, T., Shimizu, A. and Honjo, T. (1989). T-cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood, 73, 1809-1813.
36. Mosmann, T. R. and Coffman, R. L. (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 7, 145-173.
37. H2 subtypes: doubt no more, Immunol., Today, 12, 256-257.
38. Paul, W. E. and Seder, R. A. (1994). Lymphocyte response and cytokines. Cell, 76, 241-251.
39. Jaffe, J. S., James, S. P., Mullins, G. E., Braun-Elwert, L., Lubensky, I. and Metcalfe, D. D. (1994). Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and γ-interferon (γ-IFN) in peripheral blood T-cells from patients with allergic eosinophilic gastroenteritis. J. Clin. Immunol., 14, 299-309.
40. Desenne, J. J., Acquatella, G., Stern, R., Muller, A., Sanchez, M. and Somoza, R. (1992). Blood eosinophilia in Hodgkin's disease-A follow-up of 25 cases in Venezuela. Cancer, 69, 1248-1453.
41. Abruzzo, L. V., Jafe, E. S., Cotelingam, J. D., Whang-Peng, J., Del Duca, V. J. and Medeiros, L. J. (1992). T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am. J. Surg. Pathol., 16, 236-245.
42. Murata, K., Yamada, Y., Kamihara, S., Atogami, S., Tsukasaki, K., Morita, S., Amagasaki, T., Sadamori, N., Tomonaga, M., Kinosita, K. I. and Ichimaru, M. (1992). Frequency of eosinophilia in adult T-cell leukemia/ lymphoma. Cancer, 69, 966-971.
43. Hattori, T., Uchiyama, T., Toibara, T., Takatsuki, K. and Uchino, H. (1981). Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood, 58, 645-647.
44. Yamada, Y. (1983). Phenotype and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/ lymphoma. Blood, 61, 446-453.
45. Uchiyama, T., Hori, T., Tsudo, M., Wano, Y., Umadome, H., Tamori, S., Yodoi, J., Maeda, M., Sawami, H. and Uchino, H. (1985). Interleukin-2 receptor (Tac antigen) expressed on adult T-cell leukemia cells. J. Clin. Invest., 76, 446-453.
46. Keidan, A. J., Catovsky, D., Tavares de Castro, J. and Spry, C. J. (1985). Hypereosinophilic syndrome preceding T-cell lymphoblastic lymphoma. Clin. Lab. Haematol, 7, 83-88.
47. O'Shea, J. J., Jaffe, E. S., Lane, H. C., MacDermott, R. P. and Fauci, A. S. (1987). Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. Am. J. Med., 82, 539-545.
48. Kim, C. J., Park, S. H. and Chi, J. G. (1990). Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer, 67, 1064-1069.
49. Bagot, M., Bodemer, C. and Wechsler, J. (1990). Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome. Ann. Dermatol. Venereol., 117, 883-885.
50. Mraillon, I., Bagot, M., Bouraerias, I., Prin, L., Wechsler, J. and Revuz, J. (1991). Hypereosinophilic syndrome with pachyderma preceding lymphoma: treatment with interferon alpha. Ann. Dermatol. Venereol., 118, 883-885.
51. - cells bearing the α/β or the γ/δ T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes. Clini. Immunol. Immunop., 60, 371-383.
52. Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. and Mizoguchi, H. (1993). Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia, 7, 782-788.
53. - T-cells bearing T-cell receptor α and β chains in two normal men. Blood, 79, 2965.
54. - subset. J. Exp. Med, 177, 1763.
55. Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J. S. and Gleich, G. J. (1991). Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J. Exp. Medi., 174, 745-748.
56. Yousefi, S., Hemmann, S., Weber, S., Holzer, C., Hartung, K., Blaser, K. and Simon, H.-U. (1995). Interleukin-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J. Immunol., 154, 5481-5490.
57. Horie, S., Okubo, Y., Suzuki, J. and Isobe, M. (1996). An emanciated man with eosinophilic pneumonia. Lancet, 348, 166.
58. Arthur, D. C. and Bloomfield, C. D. (1983). Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood. 61, 994-998.
59. Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M. and Rowley, J. D. (1983). Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N. Engl. J. Med., 309, 630-636.
60. Bitter, M. A., Le Beau, M. M., Larson, R. A., Rosnea, M. C., Golomb, H. M., Rowley, J. D. and Vardiman, J. W. (1984). A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13;q22). Am. J. Clin. Pathol., 81, 733-741.
61. Testa, J. R., Hogge, D. E., Misawa, S. and Zandparsa, N. (1984). Chromosome 16 rearrangement in acute myelomonocytic leukemia with abnormal eosinophils. N. Engl. J. Med., 310, 468-469.
62. Campbell, H. D., Tucker, W. Q., Hort, Y., Martinson, M. E., Mayo, G., Clutterbuck, E. J., Sanderson, C. J. and Young, I. G. (1987). Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). P roc. Natl. Acad. Sci. USA, 84, 6629-6633.
63. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J. and Collins, F. S. (1993). Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science, 261, 1041-1044.
64. Swirsky, D. M., Li, Y. S., Mattews, J. G., Flemans, R. J., Rees, J. K. H. and Hayhoe, F. G. J. (1984). 8;21 translocation in acute granulocytic leukemia: Cytological, cytochemical and clinical features. Br. J. Haematol., 56, 199-213.
65. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. and Ohki, M. (1993). The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcripts. EMBO J., 12, 2715-2721.